Over 77% Of All Shares Voted; Proposals Received Overwhelming Positive Votes BETHESDA, Md., July 3, 2024 /PRNewswire/ — Northwest Biotherapeutics (OTCQB: NWBO) (“NW Bio”), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, reported positive…